BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

108 related articles for article (PubMed ID: 22251898)

  • 1. Methamphetamine: history, pathophysiology, adverse health effects, current trends, and hazards associated with the clandestine manufacture of methamphetamine. Foreword.
    Leikin JB
    Dis Mon; 2012 Feb; 58(2):37. PubMed ID: 22251898
    [No Abstract]   [Full Text] [Related]  

  • 2. Methamphetamine: history, pathophysiology, adverse health effects, current trends, and hazards associated with the clandestine manufacture of methamphetamine.
    Vearrier D; Greenberg MI; Miller SN; Okaneku JT; Haggerty DA
    Dis Mon; 2012 Feb; 58(2):38-89. PubMed ID: 22251899
    [No Abstract]   [Full Text] [Related]  

  • 3. The environmental impact and adverse health effects of the clandestine manufacture of methamphetamine.
    Irvine GD; Chin L
    NIDA Res Monogr; 1991; 115():33-46. PubMed ID: 1758481
    [No Abstract]   [Full Text] [Related]  

  • 4. [Mephedrone: a designer drug of recent use in France].
    Debruyne D; Courné MA; Le Boisselier R; Djezzar S; Gérardin M; Boucher A; Karila L; Coquerel A; Mallaret M
    Therapie; 2010; 65(6):519-24. PubMed ID: 21176758
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Evidence of methamphetamine exposure in children removed from clandestine methamphetamine laboratories.
    Grant P; Bell K; Stewart D; Paulson J; Rogers K
    Pediatr Emerg Care; 2010 Jan; 26(1):10-4. PubMed ID: 20042914
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Epidemiology of methamphetamine abuse in Missouri.
    Topolski JM
    Mo Med; 2007; 104(1):82-8. PubMed ID: 17410832
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Anatomical substrates for the discriminative stimulus effects of methamphetamine in rats.
    Nakajima A; Yamada K; He J; Zeng N; Nitta A; Nabeshima T
    J Neurochem; 2004 Oct; 91(2):308-17. PubMed ID: 15447664
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Hair drug testing of children suspected of exposure to the manufacture of methamphetamine.
    Farst K; Reading Meyer JA; Mac Bird T; James L; Robbins JM
    J Forensic Leg Med; 2011 Apr; 18(3):110-4. PubMed ID: 21420647
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Changing over-the-counter ephedrine and pseudoephedrine products to prescription only: impacts on methamphetamine clandestine laboratory seizures.
    Cunningham JK; Callaghan RC; Tong D; Liu LM; Li HY; Lattyak WJ
    Drug Alcohol Depend; 2012 Nov; 126(1-2):55-64. PubMed ID: 22592141
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The epidemiology of methamphetamine use and harm in Australia.
    Degenhardt L; Roxburgh A; Black E; Bruno R; Campbell G; Kinner S; Fetherston J
    Drug Alcohol Rev; 2008 May; 27(3):243-52. PubMed ID: 18368605
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Designer drugs: a medicinal chemistry perspective.
    Carroll FI; Lewin AH; Mascarella SW; Seltzman HH; Reddy PA
    Ann N Y Acad Sci; 2012 Feb; 1248():18-38. PubMed ID: 22092008
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Are methamphetamine precursor control laws effective tools to fight the methamphetamine epidemic?
    Nonnemaker J; Engelen M; Shive D
    Health Econ; 2011 May; 20(5):519-31. PubMed ID: 21433216
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Exposures associated with clandestine methamphetamine drug laboratories in Australia.
    Wright J; Edwards J; Walker S
    Rev Environ Health; 2016 Sep; 31(3):329-52. PubMed ID: 27428841
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The rise of methamphetamine in Southeast and East Asia.
    McKetin R; Kozel N; Douglas J; Ali R; Vicknasingam B; Lund J; Li JH
    Drug Alcohol Rev; 2008 May; 27(3):220-8. PubMed ID: 18368602
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Major physical and psychological harms of methamphetamine use.
    Darke S; Kaye S; McKetin R; Duflou J
    Drug Alcohol Rev; 2008 May; 27(3):253-62. PubMed ID: 18368606
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Methamphetamine abuse.
    Winslow BT; Voorhees KI; Pehl KA
    Am Fam Physician; 2007 Oct; 76(8):1169-74. PubMed ID: 17990840
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Pseudoephedrine and methamphetamine and the legal opposition.
    Caldwell GB
    J Okla State Med Assoc; 2012 Feb; 105(2):47. PubMed ID: 22586871
    [No Abstract]   [Full Text] [Related]  

  • 18. Methamphetamine: an epidemic of oral health neglect, loss of access to care, abuse, and violence.
    Assael LA
    J Oral Maxillofac Surg; 2005 Sep; 63(9):1253-4. PubMed ID: 16122586
    [No Abstract]   [Full Text] [Related]  

  • 19. A qualitative study of sexual behaviours among methamphetamine users in Chiang Mai, Thailand: a typology of risk.
    Sherman SG; Gann D; German D; Sirirojn B; Thompson N; Aramrattana A; Celentano D
    Drug Alcohol Rev; 2008 May; 27(3):263-9. PubMed ID: 18368607
    [TBL] [Abstract][Full Text] [Related]  

  • 20. A review of the clinical pharmacology of methamphetamine.
    Cruickshank CC; Dyer KR
    Addiction; 2009 Jul; 104(7):1085-99. PubMed ID: 19426289
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.